Press Release Archive
Press Releases
March 2024
03.12.2024
November 2023
11.02.2023
June 2023
06.26.2023
Research and Pipeline Research Pfizer Provides Update on GLP-1-RA Clinical Development Program for Adults with Obesity and Type 2 Diabetes Mellitus
06.01.2023
December 2022
12.29.2022
12.01.2022
Financial Finance Medicines Research Vaccines Pfizer Invites Public to Register for Webcast of Pfizer Near-Term Launches + High-Value Pipeline Day
12.01.2022
October 2022
10.04.2022
Research and Pipeline Research Pfizer Announces Positive Topline Results from Phase 3 TALAPRO-2 Trial
September 2022
09.19.2022
Research and Pipeline Research Vaccines Pfizer Announces Positive Top-Line Results from Phase 3 Study in 20-Valent Pneumococcal Conjugate Vaccine in Infants in the European Union
09.14.2022
Research and Pipeline Research Pfizer Initiates Phase 3 Study of mRNA-Based Influenza Vaccine
August 2022
08.08.2022
Research and Pipeline Research Pfizer and Valneva Initiate Phase 3 Study of Lyme Disease Vaccine Candidate VLA15
June 2022
06.17.2022
Media Resources & Contact Information
Anyone may view our press releases, press statements, and press kits.
However, to ensure that customers, investors, and others receive the appropriate attention, Pfizer media contacts may only respond to calls and emails from professional journalists.